Label Changes for:

Inderide (propranolol HCl/hydrochlorothiazide) tablets

March 2010

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2010

ADVERSE REACTIONS

Hydrochlorothiazide
  • Skin: Erythema multiforme including Steven-Johnson syndrome, exfoliative dermatitis, including toxic epidermal necrolysis
Hide
(web5)